Bristol Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . Bristol Myers Squibb
BMY Stock  USD 59.99  0.98  1.66%   
Bristol Myers financial statements provide useful quarterly and yearly information to potential Bristol Myers Squibb investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Bristol Myers financial statements helps investors assess Bristol Myers' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Bristol Myers' valuation are summarized below:
Gross Profit
36.4 B
Profit Margin
(0.19)
Market Capitalization
119.7 B
Enterprise Value Revenue
3.3145
Revenue
48.3 B
We have found one hundred twenty available fundamental signals for Bristol Myers Squibb, which can be analyzed and compared to other ratios and to its rivals. All investors should make sure to validate all of Bristol Myers Squibb prevailing market performance against the performance between 2010 and 2025 to make sure the company can sustain itself down the road. Market Cap is likely to rise to about 108.3 B in 2025. Enterprise Value is likely to rise to about 146.9 B in 2025

Bristol Myers Total Revenue

50.72 Billion

Check Bristol Myers financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bristol Myers' main balance sheet or income statement drivers, such as Depreciation And Amortization of 10.1 B, Interest Expense of 2 B or Selling General Administrative of 8.8 B, as well as many indicators such as Price To Sales Ratio of 2.95, Dividend Yield of 0.0274 or PTB Ratio of 6.94. Bristol financial statements analysis is a perfect complement when working with Bristol Myers Valuation or Volatility modules.
  
Check out the analysis of Bristol Myers Correlation against competitors.

Bristol Myers Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets97.2 B92.6 B62.4 B
Slightly volatile
Short and Long Term Debt Total53.8 B51.2 B24.4 B
Slightly volatile
Total Current Liabilities25 B23.8 B13.7 B
Slightly volatile
Total Stockholder Equity15.1 B16.3 B21.1 B
Slightly volatile
Property Plant And Equipment Net5.3 B7.1 B5.5 B
Slightly volatile
Retained Earnings21.9 B14.9 B27.3 B
Pretty Stable
Cash10.9 B10.3 B7.5 B
Slightly volatile
Non Current Assets Total66 B62.8 B42.1 B
Slightly volatile
Cash And Short Term Investments5.8 B10.9 B7.7 B
Slightly volatile
Net Receivables11.3 B10.7 B7.3 B
Slightly volatile
Good Will22.8 B21.7 B12.8 B
Slightly volatile
Common Stock Shares Outstanding1.6 B2 B1.8 B
Slightly volatile
Liabilities And Stockholders Equity97.2 B92.6 B63 B
Slightly volatile
Non Current Liabilities Total55.1 B52.4 B28 B
Slightly volatile
Inventory1.9 B2.6 B1.9 B
Slightly volatile
Other Current Assets5.9 B5.6 B3.1 B
Very volatile
Total Liabilities80 B76.2 B41.7 B
Slightly volatile
Property Plant And Equipment Gross14 B13.3 B7.2 B
Slightly volatile
Total Current Assets31.3 B29.8 B20.3 B
Slightly volatile
Short Term Debt1.1 B2.2 B1.8 B
Slightly volatile
Intangible Assets24.5 B23.3 B18.3 B
Slightly volatile
Accounts Payable1.9 B3.6 B2.4 B
Slightly volatile
Common Stock Total Equity255.5 M335.8 M252.3 M
Slightly volatile
Short Term Investments487.4 M513 M1.5 B
Pretty Stable
Capital Stock260.5 M335.8 M252.6 M
Slightly volatile
Common Stock260.5 M335.8 M252.6 M
Slightly volatile
Other Liabilities4.9 B8.5 B6.3 B
Slightly volatile
Other Assets3.3 B3.3 B3 B
Slightly volatile
Long Term Debt50 B47.6 B22.1 B
Slightly volatile
Property Plant Equipment5.8 B7.2 B5.4 B
Slightly volatile
Current Deferred Revenue296.1 M311.6 M1.5 B
Very volatile
Retained Earnings Total Equity24.5 B23 B29.4 B
Slightly volatile
Long Term Debt Total42.3 B40.3 B21.4 B
Slightly volatile
Capital Surpluse54.5 B51.9 B21.8 B
Slightly volatile
Deferred Long Term Liabilities2.2 B2.5 B2.2 B
Slightly volatile
Long Term Investments2 B2.5 B2.5 B
Slightly volatile
Non Current Liabilities Other495.9 M522 M3.7 B
Very volatile
Deferred Long Term Asset Charges557.2 M586.5 M1 B
Slightly volatile
Short and Long Term Debt2.8 B2 B4.5 B
Slightly volatile
Cash And Equivalents10.5 B10.5 B7.6 B
Slightly volatile
Net Invested Capital70.7 B66 B45.2 B
Slightly volatile
Net Working Capital9.1 B6 B7 B
Slightly volatile
Capital Lease Obligations1.4 B1.6 B1 B
Slightly volatile

Bristol Myers Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization10.1 B9.6 B4.2 B
Slightly volatile
Selling General Administrative8.8 B8.4 B4.1 B
Slightly volatile
Total Revenue50.7 B48.3 B29 B
Slightly volatile
Gross Profit38.2 B36.4 B21.6 B
Slightly volatile
Other Operating Expenses17 B19.6 B20.4 B
Slightly volatile
Operating Income30.2 B28.7 B8.7 B
Slightly volatile
EBITDA3 B3.2 B7.2 B
Slightly volatile
Cost Of Revenue6 B11.9 B6.9 B
Slightly volatile
Total Operating Expenses11.3 B19.6 B14.3 B
Slightly volatile
Research Development11.7 B11.2 B6.9 B
Slightly volatile
Selling And Marketing Expenses1.5 B1.6 B4.3 B
Very volatile
Discontinued Operations6 B6.7 B7.3 B
Slightly volatile
Non Recurring2.2 B2.1 B1.7 B
Slightly volatile
Tax Provision526.3 M554 M1 B
Pretty Stable
Interest Income2.2 B2.1 B582.6 M
Slightly volatile
Reconciled Depreciation7.2 B9.6 B4.1 B
Slightly volatile

Bristol Myers Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Free Cash Flow14.6 B13.9 B7.4 B
Slightly volatile
Begin Period Cash Flow12.1 B11.5 B7.3 B
Slightly volatile
Depreciation10.1 B9.6 B4.2 B
Slightly volatile
Dividends Paid2.6 B4.9 B3 B
Slightly volatile
Capital Expenditures852.4 M1.2 B847.7 M
Slightly volatile
Total Cash From Operating Activities15.9 B15.2 B8.2 B
Slightly volatile
End Period Cash Flow5.3 B10.3 B7.2 B
Slightly volatile
Stock Based Compensation275 M507 M376.8 M
Pretty Stable

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio2.952.37363.8898
Slightly volatile
Dividend Yield0.02740.04240.0306
Pretty Stable
PTB Ratio6.947.01855.34
Very volatile
Days Sales Outstanding60.0781.214487.6676
Slightly volatile
Book Value Per Share5.628.084910.7234
Slightly volatile
Free Cash Flow Yield0.130.12160.0701
Slightly volatile
Operating Cash Flow Per Share7.877.49384.2332
Slightly volatile
Stock Based Compensation To Revenue0.00870.01050.0113
Pretty Stable
Capex To Depreciation0.120.130.9526
Slightly volatile
PB Ratio6.947.01855.34
Very volatile
EV To Sales3.13.21954.2837
Pretty Stable
Free Cash Flow Per Share7.226.87813.7622
Slightly volatile
ROIC0.210.250.1411
Pretty Stable
Inventory Turnover2.584.67313.7813
Slightly volatile
Days Of Inventory On Hand14278.1074107
Slightly volatile
Payables Turnover3.813.31733.0747
Slightly volatile
Sales General And Administrative To Revenue0.180.160.1052
Slightly volatile
Research And Ddevelopement To Revenue0.140.2310.2319
Very volatile
Capex To Revenue0.04430.02580.0357
Slightly volatile
Cash Per Share5.635.35724.7607
Slightly volatile
POCF Ratio7.177.547518.5028
Slightly volatile
Interest Coverage20.5617.0116.6716
Slightly volatile
Capex To Operating Cash Flow0.07810.08220.1703
Slightly volatile
PFCF Ratio8.638.223126.2108
Slightly volatile
Days Payables Outstanding91.31110130
Slightly volatile
EV To Operating Cash Flow9.7310.237120.0898
Slightly volatile
EV To Free Cash Flow11.7111.153428.1173
Slightly volatile
Intangibles To Total Assets0.510.48620.4175
Slightly volatile
Current Ratio1.941.25261.8068
Very volatile
Receivables Turnover5.594.49434.3493
Slightly volatile
Shareholders Equity Per Share5.748.058711.1076
Slightly volatile
Debt To Equity3.293.13441.056
Slightly volatile
Capex Per Share0.320.61570.4503
Slightly volatile
Revenue Per Share25.0223.828315.0914
Slightly volatile
Interest Debt Per Share27.5326.219512.6867
Slightly volatile
Debt To Assets0.580.55290.3411
Slightly volatile
Enterprise Value Over EBITDA51.5449.08522.3977
Slightly volatile
Graham Number33.331.7123.9326
Slightly volatile
Short Term Coverage Ratios11.487.42428.3078
Slightly volatile
Operating Cycle223159196
Very volatile
Price Book Value Ratio6.947.01855.34
Very volatile
Days Of Payables Outstanding91.31110130
Slightly volatile
Price To Operating Cash Flows Ratio7.177.547518.5028
Slightly volatile
Price To Free Cash Flows Ratio8.638.223126.2108
Slightly volatile
Operating Profit Margin0.250.440.2246
Slightly volatile
Company Equity Multiplier5.955.6692.8555
Slightly volatile
Long Term Debt To Capitalization0.780.74450.4183
Slightly volatile
Total Debt To Capitalization0.80.75810.4451
Slightly volatile
Return On Capital Employed0.290.270.1863
Very volatile
Debt Equity Ratio3.293.13441.056
Slightly volatile
Ebit Per Revenue0.250.440.2246
Slightly volatile
Quick Ratio1.191.14511.5718
Pretty Stable
Dividend Paid And Capex Coverage Ratio2.612.48571.8689
Slightly volatile
Net Income Per E B T0.651.06790.7893
Slightly volatile
Cash Ratio0.50.43520.771
Very volatile
Operating Cash Flow Sales Ratio0.170.31450.2503
Slightly volatile
Days Of Inventory Outstanding14278.1074107
Slightly volatile
Days Of Sales Outstanding60.0781.214487.6676
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.610.91780.8103
Pretty Stable
Cash Flow Coverage Ratios0.280.29670.5714
Slightly volatile
Price To Book Ratio6.947.01855.34
Very volatile
Fixed Asset Turnover7.116.76854.887
Slightly volatile
Capital Expenditure Coverage Ratio12.7812.17159.4204
Slightly volatile
Price Cash Flow Ratio7.177.547518.5028
Slightly volatile
Enterprise Value Multiple51.5449.08522.3977
Slightly volatile
Debt Ratio0.580.55290.3411
Slightly volatile
Cash Flow To Debt Ratio0.280.29670.5714
Slightly volatile
Price Sales Ratio2.952.37363.8898
Slightly volatile
Asset Turnover0.870.52160.6372
Very volatile
Gross Profit Margin0.80.75260.7428
Slightly volatile
Price Fair Value6.947.01855.34
Very volatile

Bristol Myers Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap108.3 B103.2 B100.9 B
Slightly volatile
Enterprise Value146.9 B140 B127.6 B
Slightly volatile

Bristol Fundamental Market Drivers

Forward Price Earnings8.7336
Cash And Short Term Investments10.9 B

Bristol Upcoming Events

2nd of February 2024
Upcoming Quarterly Report
View
25th of April 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
2nd of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Bristol Myers Financial Statements

Bristol Myers investors use historical fundamental indicators, such as Bristol Myers' revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Bristol Myers. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue311.6 M296.1 M
Total Revenue48.3 B50.7 B
Cost Of Revenue11.9 B6 B
Stock Based Compensation To Revenue 0.01  0.01 
Sales General And Administrative To Revenue 0.16  0.18 
Research And Ddevelopement To Revenue 0.23  0.14 
Capex To Revenue 0.03  0.04 
Revenue Per Share 23.83  25.02 
Ebit Per Revenue 0.44  0.25 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
VVisa Class A
CRMSalesforce
CRMSalesforce

Additional Tools for Bristol Stock Analysis

When running Bristol Myers' price analysis, check to measure Bristol Myers' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bristol Myers is operating at the current time. Most of Bristol Myers' value examination focuses on studying past and present price action to predict the probability of Bristol Myers' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bristol Myers' price. Additionally, you may evaluate how the addition of Bristol Myers to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY